Description

Learn about Psychedelic Psychopharmacology in our 12-week reading and study group or on-demand webinar. See the individual courses for an in-depth description of each offering.

Learning Objectives

  • Describe pharmacokinetic properties of psilocybin to predict potential drug interactions and adverse effects.
  • Describe pharmacokinetic properties of ayahuasca to predict potential drug interactions and adverse effects.
  • Describe pharmacokinetic properties of MDMA to predict potential drug interactions and adverse effects.
  • Describe pharmacokinetic properties of ketamine to predict potential drug interactions and adverse effects.
  • Explain how the pharmacodynamics of psilocybin affects clinical and serological biomarkers.
  • Explain how the pharmacodynamics of ayahuasca affects clinical and serological biomarkers.
  • Explain how the pharmacodynamics of MDMA affects clinical and serological biomarkers.
  • Explain how the pharmacodynamics of ketamine affects clinical and serological biomarkers.
  • Discuss the effects of psilocybin on neural network function.
  • Discuss the effects of ayahuasca on neural network function.
  • Discuss the effects of MDMA on neural network function.
  • Discuss the effects of ketamine on neural network function.

Details

Format

Online On-Demand Live

Cost

Varies

Continuing Education Credit

See individual courses

Topic

Ketamine Psilocybin MDMA

Type

Webinar Reading & Study Group Elective